MedPath

Endometriosis and Brominated Flame Retardant (ENDOTOX Study)

Completed
Conditions
Endometriosis
Registration Number
NCT02651077
Lead Sponsor
Nantes University Hospital
Brief Summary

The investigators wish to highlight, in a Case-Control design, if there is an increased concentration of BFRs in omental adipose tissue of cases ( women with severe endometriosis with surgical indication ) versus bioaccumulation recorded in a control cohort ( women recruited in obstetrics and gynecology or visceral surgery showing no sign of endometriosis ) . Pairing will be operate on Age (+/- 5 years compared to the case ) , BMI ( BMI 5 Classes described by the HAS) and previous breastfeeding experience (yes / no , opposite the release expected bioaccumulate contaminants in breast adipose tissue , when the lactation ) .

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
76
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Concentrations of brominated flame retardant (BFR) in adipose tissue and serumbaseline
Secondary Outcome Measures
NameTimeMethod
Concentrations of dioxins in adipose tissue and serumbaseline
Concentrations of polychlorinated biphenyls (PCBs),baseline
Concentrations of organochlorine pesticides (OCPs) in adipose tissue and serumbaseline

Trial Locations

Locations (1)

Nantes University Hospital

🇫🇷

Nantes, France

© Copyright 2025. All Rights Reserved by MedPath